125459 -

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

The guideline, officially titled , provides a framework for non-clinical studies required before a gene therapy can be used in human clinical trials. Guide to EMA Guideline 125459 125459

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy. For more detailed technical specifications, you can access

: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations. : Evaluating whether the viral vector or therapeutic

: Assessing the risk of "insertional mutagenesis"—where the therapy might accidentally interfere with the patient's existing DNA.

This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects.

: Determining where the therapeutic gene goes in the body and how long it persists in both target and non-target cells.